Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Alabama for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Alabama only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Alabama (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Alexander Talalight (NPI 1700094661)

Field	Value
Entity Type	Individual
Organization	Alexander Talalight
Address	2331 Whitesburg Dr S
City	Huntsville
State	AL
ZIP	35801
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	May 21, 2007

Payer Source	Total Paid
Medicare	$1.4M
Medicaid	$0

Key Findings

This provider’s Medicare revenue is highly concentrated: the precomputed top 3 Medicare codes by revenue account for 77.0% of this provider's total Medicare revenue, with J0178 alone contributing $802.2K (58.4% of total Medicare revenue) and the next two codes J0178, 67028 and J2777 together dominating the practice’s billings. That concentration indicates a business model centered on high-frequency intravitreal pharmacologic therapy rather than broad multispecialty services.

Clinical service mix is consistent with a retina-focused ophthalmology practice: the single largest revenue driver is J0178 (aflibercept) at $802.2K and 1.2K claims, supported by substantial billing for other injectable agents (J2777 faricimab at $125.3K and J9035 bevacizumab at $62.4K) and retina diagnostics (92134 at $57K). The presence of high-volume injection codes alongside retinal imaging (92134) and follow-up E&M codes suggests the operation runs frequent injection clinics with integrated diagnostic imaging and office visits.

Payer mix is effectively single-payer Medicare: lifetime Medicare revenue is $1.4M while there is no Medicaid billing on file, so the provider’s public-fee revenue and utilization signals should be interpreted without Medicaid comparators. This single-payer footprint limits insight into any Medicaid-facing service lines or state-program behavior for this NPI.

Competitive standing is moderate for the dominant drug: J0178 ranks #1110 of 3204 providers nationally (65th percentile; typical, unremarkable volume), indicating the provider is an active aflibercept user but not a national high-volume outlier for this agent. By contrast, some ancillary services show much stronger relative volume—these mixed rankings point to a practice that is regionally busy but not a top national injector for every retina drug.

Several codes show notably above-typical national volume for non-drug services: 92134 (retinal imaging) ranks #1006 of 26868 providers nationally (96th percentile; notably above typical national volume) and 99213 (established E&M) ranks #10121 of 457151 providers nationally (98th percentile; notably above typical national volume). These high percentiles for imaging and E&M imply a consistent patient flow and frequent follow-up visits, supporting the interpretation of an active injection clinic with substantial diagnostic throughput.

There is a visible preference pattern across anti-VEGF agents: J0178 (aflibercept) produces $802.2K while J2777 (faricimab) and J2778 (ranibizumab) produce $125.3K and $46.7K respectively; J2777 ranks at the 20th percentile (typical, unremarkable volume) and J2778 at the 17th percentile (typical, unremarkable volume). This distribution suggests clinical or formulary preference toward aflibercept (and continued use of bevacizumab, J9035 at $62.4K) rather than heavy utilization of faricimab or ranibizumab in this practice.

The provider has sustained tenure in the Medicare program, with the NPI enumerated on 2007-05-21 (~19 years ago), indicating a long-established practice presence that likely supports steady referral patterns and a stable patient base. Longer enrollment combined with the high imaging and E&M percentiles is consistent with an established retina clinic rather than a new or transient provider.

Surgical and laser procedures are present but represent a small portion of revenue: procedural codes such as 67036 ($9.3K), 67145 ($5.5K) and 67228 ($5.3K) appear but account for minor shares of total Medicare revenue. This mix reinforces that the practice’s primary revenue driver is office-based intravitreal therapy and diagnostic follow-up rather than frequent vitreoretinal surgery.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

17 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,180	$680	$802.2K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,500	$90	$130.6K
J2777	Injection, faricimab‑svoa, 0.1 mg	4,320	$30	$125.3K
J9035	Injection, bevacizumab, 10 mg	1,160	$50	$62.4K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,040	$30	$57K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	620	$90	$53.6K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	820	$60	$50.1K
J2778	Injection, ranibizumab, 0.1 mg	290	$160	$46.7K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	220	$70	$15.7K
67036	The provider removes vitreous fluid from the eye to access the posterior segment of the eye and introduce surgical instruments through incisions in the pars plana.	20	$620	$9.3K

Showing 1–10 of 17

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 17 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Alabama Distribution

Alexander Talalight — 4 of 17 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Alabama

Full comparison — all codes billed, vs. state median

17 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	16	40	920	$690	$706.2K
J2777	21	20	7,140	$30	$267.9K
67028	7	40	990	$90	$82.5K
J2778	5	10	290	$180	$69.9K
J9035	3	40	410	$50	$24.5K
99214	541	7,330	120	$80	$16.8K
92014	100	430	100	$80	$13.3K
67036	10	20	20	$690	$12.4K
92235	13	10	50	$90	$10.7K
67228	4	10	30	$240	$10K

Showing 1–10 of 17

Related Providers

Other providers that share a Tax Identification Number (TIN) with Alexander Talalight, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
William Mitchell	AL	Ophthalmology Physician	$562.1K	$0
Michael Salter	AL	Glaucoma Specialist (Ophthalmology) Physician	$472.6K	$0
Danny Lee	AL	Ophthalmology Physician	$407.8K	$0
Jonathan Ramsey	AL	Ophthalmology Physician	$327.6K	$0
Brian Baxter	CO	Optometrist	$112.7K	$0
Brenda Miller Edmonson	AL	Ophthalmology Physician	$112K	$0
Stephen Solomon	AL	Neuro-ophthalmology Physician	$54.7K	$21.4K

Nearby Providers

Other providers in the same ZIP code as Alexander Talalight, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Tennessee Valley Neonatology, Inc	AL	Neonatal-Perinatal Medicine Physician	$0	$22.2M
The Health Care Authority Of The City Of Huntsville	AL	General Acute Care Hospital	$0	$17.8M
Happi Health	AL	Federally Qualified Health Center (FQHC)	$0	$17.6M
Emergency Physicians Group	AL	Emergency Medicine Physician	$0	$13.5M
Healthgroup Of Alabama	AL	Contractor	$0	$13.4M
The Valley Foundation	AL	Multi-Specialty Clinic/Center	$0	$11.3M
David White	AL	Neurology Physician	$7M	$0
The Children's Hospital Of Alabama	AL	Pediatric Pulmonology Physician	$0	$5.6M
Huntsville Pediatric Associates, LLC	AL	Pediatrics Physician	$0	$4.8M
Dental Associates Of Huntsville, LLC	AL	General Practice Dentistry	$0	$4.7M

Alexander Talalight — Billing Profile & Reimbursement Data

Sign up for Alexander Talalight — Billing Profile & Reimbursement Data policy alerts

Alexander Talalight — Billing Profile & Reimbursement Data

Sign up for Alexander Talalight — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References